AstraZeneca Bets Big on China with 100+ New Medicines in 5 Years 

AstraZeneca plans to launch over 100 new medicines in China through its Shanghai R&D hub, aiming to boost global health innovation.
NewspaperAmigo – Your Global News Buddy
Timely Reports, Friendly Voices – Your Daily News Amigo
AstraZeneca plans to launch over 100 new medicines in China through its Shanghai R&D hub, aiming to boost global health innovation.